Literature DB >> 20523809

Kaposi sarcoma after corticosteroid therapy for idiopathic thrombocytopenic purpura.

Kwang Hyun Choi1, Jae Ho Byun, Jun Young Lee, Baik Kee Cho, Hyun Jeong Park.   

Abstract

Kaposi sarcoma (KS) is a multifocal vascular neoplasm most commonly seen in association with human immunodeficiency virus infection. However, KS has also been reported in patients treated with immunosuppressive agents. However, it is very rare to find KS in association with idiopathic thrombocytopenic purpura (ITP). Here we describe a 58-year-old male patient suffering from ITP treated with corticosteroid therapy who developed KS and present a review of the literature.

Entities:  

Keywords:  Corticosteroid; Idiopathic thrombocytopenic purpura; Kaposi sarcoma

Year:  2009        PMID: 20523809      PMCID: PMC2861229          DOI: 10.5021/ad.2009.21.3.297

Source DB:  PubMed          Journal:  Ann Dermatol        ISSN: 1013-9087            Impact factor:   1.444


  11 in total

Review 1.  Rheumatoid arthritis, corticosteroid therapy and Kaposi's sarcoma: a coincidence? A case and review of literature.

Authors:  P Casoli; B Tumiati
Journal:  Clin Rheumatol       Date:  1992-09       Impact factor: 2.980

2.  Kaposi's sarcoma, rheumatoid arthritis and immunosuppressive and/or corticosteroid therapy.

Authors:  P Casoli; B Tumiati
Journal:  J Rheumatol       Date:  1992-08       Impact factor: 4.666

3.  Kaposi's sarcoma in a human immunodeficiency virus-negative patient treated with corticosteroid for idiopathic thrombocytopenic purpura.

Authors:  Tamiko Toyohama; Akitoshi Nagasaki; Jun-ichi Miyagi; Wakako Takamine; Keishin Sunagawa; Hiroshi Uezato; Naoya Taira; Masato Masuda; Nobuyuki Takasu
Journal:  Intern Med       Date:  2003-05       Impact factor: 1.271

4.  [Kaposi's sarcoma developing during corticosteroid therapy in idiopathic thrombocytopenic purpura].

Authors:  M Kohno; M Miyata; A Ohmoto; R Matsuyama
Journal:  Rinsho Ketsueki       Date:  1989-08

5.  Idiopathic thrombocytopenic purpura and Kaposi's sarcoma.

Authors:  A Turnbull; J Almeyda
Journal:  Proc R Soc Med       Date:  1970-06

6.  Nuclear binding of glucocorticoid receptors: relations between cytosol binding, activation and the biological response.

Authors:  E Bloom; D T Matulich; N C Lan; S J Higgins; S S Simons; J D Baxter
Journal:  J Steroid Biochem       Date:  1980-01       Impact factor: 4.292

7.  Kaposi's sarcoma in an HIV-negative CLL patient as the cause of thrombocytopenia.

Authors:  P W Wijermans; K van Groningen; E A van Royen; J A Bruijn
Journal:  Ann Hematol       Date:  1994-06       Impact factor: 3.673

8.  Kaposi's sarcoma in organ transplant recipients: report of 20 cases.

Authors:  I Penn
Journal:  Transplantation       Date:  1979-01       Impact factor: 4.939

9.  The appearance of Kaposi sarcoma during corticosteroid therapy.

Authors:  A Trattner; E Hodak; M David; M Sandbank
Journal:  Cancer       Date:  1993-09-01       Impact factor: 6.860

10.  Glucocorticoids inhibit apoptosis during fibrosarcoma development by transcriptionally activating Bcl-xL.

Authors:  Duncan M Gascoyne; Robert M Kypta; Maria d M Vivanco
Journal:  J Biol Chem       Date:  2003-03-12       Impact factor: 5.157

View more
  4 in total

1.  Iatrogenic Kaposi's sarcoma caused by corticosteroids.

Authors:  Rosana Lazzarini; Andressa Sato de Aquino Lopes; Rute Facchini Lellis; Fabiana Brasil
Journal:  An Bras Dermatol       Date:  2016 Nov-Dec       Impact factor: 1.896

2.  Role of radiotherapy in local control of non-AIDS associated Kaposi's sarcoma patients in Korea: a single institution experience.

Authors:  Ji Hyun Chang; Il Han Kim
Journal:  Radiat Oncol J       Date:  2012-12-31

3.  The Spectrum of Underlying Causes of Iatrogenic Kaposi's Sarcoma in a Large Series: A Retrospective Study.

Authors:  Can Baykal; Tugba Atci; Nesimi Buyukbabani; Armagan Kutlay
Journal:  Indian J Dermatol       Date:  2019 Sep-Oct       Impact factor: 1.494

Review 4.  A Review on Secondary Immune Thrombocytopenia in Malaysia.

Authors:  Muhamad Aidil Zahidin; Noor Haslina Mohd Noor; Muhammad Farid Johan; Abu Dzarr Abdullah; Zefarina Zulkafli; Hisham Atan Edinur
Journal:  Healthcare (Basel)       Date:  2021-12-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.